ghk cu antibody formation neutralizing antibodies Biological injections vs GHK-cu peptide, based on clinical study Understanding Immunogenicity Risks in Injectable

Is BPC-157 legal and FDA-approved

Why combine cagrilintide with tirzepatide: theoretical rationale The mechanistic case for synergy exists on paper

What It Targets Our Epithalon + GHK-Cu combination peptides are designed to target: Cellular aging pathways, including telomere attrition, oxidative stress, and circadian disruption in midlife and beyond. Sleep quality and recovery in clients with agerelated melatonin decline, tired but wired evenings, or irregular sleepwake cycles. Visible skin agingfine lines, laxity, dullness, and textural changesthrough enhanced collagen, elastin, and dermal remodeling. Overall biological age markers in clients already investing in nutrition, exercise, stress work, and other Better Med Spa protocols (GLP1s, Tesamorelin, etc.)

Its also a substrate for SIRT1, a family of enzymes involved in DNA repair, DNA silencing and metabolic regulation